ABSTRACT
Purpose To evaluate the utility of modified Harvard Step tests within the context of a comprehensive physical examination for fitness evaluation and exercise prescription for cancer survivors.
Methods A retrospective chart review of initial cancer survivor clinic visits over a ten-year period (n=169) was conducted to evaluate correlations between demographic factors, clinical characteristics, step and strength test performance, and exercise prescriptions.
Results Clinic population was 94% female, aged 27-79 years, predominantly breast cancer (87%), presenting within two years of cancer diagnosis with current exercise history significantly less vigorous than past exercise (p=0.00; 34% sedentary). Fifty-two percent completed a 3-minute-9-inch step test at pace (96 steps per minute). Fourteen percent required slower self-pacing, 12% both a slower pace and shortened time, and 5% a flat test. Younger age (p=0.04) and more vigorous exercise histories (p<0.04) correlated with ability to complete the at pace test but all formats led to exercise prescriptions more vigorous than current activity (p<0.0002). Stratified fitness ratings using YMCA normative data yielded associations between higher fitness levels and lower BMI (F(1,86)=4.149, p<0.05), office pulse (F(1,87)=7.677, p<0.05), and systolic blood pressure (F(1,18)=6.58, p<0.05).
Conclusions Office-based fitness evaluation with a panel of modified step test options accommodating different baseline fitness levels enabled personalized exercise prescriptions more vigorous than current activity.
Implications for Cancer Survivors Cancer patients frequently engage in less vigorous activity as they enter into survivorship. Modified step tests are a means for office-based evaluation of cardiovascular fitness within the context of a comprehensive physical examination.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding information. Partial financial support was received from Georgetown University School of Medicine Dean's Research Award (K.R.W.) and National Institutes of Health, National Cancer Institute 5P30CA051008 (P.A.F.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Georgetown University Institutional Review Board and determined to impose minimal risk on participants. A waiver of consent was obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures. The authors have no relevant financial or non-financial interests to disclose.
Funding information. Partial financial support was received from Georgetown University School of Medicine Dean’s Research Award (K.R.W.) and National Institutes of Health, National Cancer Institute 5P30CA051008 (P.A.F.)
Data Availability
All data referred to in the manuscript is contained either within the Tables included in the manuscript or the supplementary figure file.